Inventor · disambiguated record
William J. Pitts
Also filed as: PITTS WILLIAM J · PITTS WILLIAM JOHN
52 granted patents·5 pending applications·1,055 citations·filing 1993–2024
98Inventor score
Files withBRISTOL MYERS SQUIBB CO41DU PONT MERCK PHARMA4DU PONT PHARM CO4PITTS WILLIAM J3BRISTOL MEYERS SQUIBB PHARMA C1
Top patents by PatentIndex Score
57 records- 0197US5593994AProstaglandin synthase inhibitorsDU PONT MERCK PHARMA·Filed 1994·Granted Jan 14, 1997·251 cites·13 claims
- 0295US7683171B21H-imidazo[4,5-d]thieno[3,2-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising sameBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Mar 23, 2010·46 cites·9 claims
- 0395US6838559B2Purine inhibitors of phosphodiesterase (PDE) 7BRISTOL MYERS SQUIBB CO·Filed 2002·Granted Jan 4, 2005·79 cites·1 claims
- 0494US6489333B2Integrin antagonistsBRISTOL MEYERS SQUIBB PHARMA C·Filed 2001·Granted Dec 3, 2002·93 cites·15 claims
- 0593US10913738B2Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Feb 9, 2021·7 cites·14 claims
- 0690US7022849B2Quinazoline and pyrido[2,3-d]pyrimidine inhibitors of phosphodiesterase (PDE) 7BRISTOL MYERS SQUIBB CO·Filed 2002·Granted Apr 4, 2006·36 cites·21 claims
- 0790US6399773B1Compounds derived from an amine nucleus that are inhibitors of IMPDH enzymeBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Jun 4, 2002·105 cites·26 claims
- 0890US6214834B1Integrin inhibitor prodrugsDU PONT PHARM CO·Filed 1998·Granted Apr 10, 2001·57 cites·42 claims
- 0989US8354398B2Substituted isoxazole compoundsBRISTOL MYERS SQUIBB CO·Filed 2010·Granted Jan 15, 2013·13 cites·12 claims
- 1089US7601836B2Pyrido[2,3-D]pyrimidine inhibitors of phosphodiesterase (PDE) 7BRISTOL MYERS SQUIBB CO·Filed 2005·Granted Oct 13, 2009·11 cites·1 claims
- 1188US8987311B2Triazolyl-substituted pyridyl compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Mar 24, 2015·14 cites·16 claims
- 1287US7087614B2Pyrimidine inhibitors of phosphodiesterase (PDE) 7BRISTOL MYERS SQUIBB CO·Filed 2002·Granted Aug 8, 2006·35 cites·7 claims
- 1386US8404672B2Substituted heterocyclic compoundsPITTS WILLIAM J·Filed 2010·Granted Mar 26, 2013·13 cites·12 claims
- 1486US7105667B2Fused heterocyclic compounds and use thereofBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Sep 12, 2006·25 cites·6 claims
- 1585US9862715B2Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jan 9, 2018·5 cites·2 claims
- 1685US8389509B2Substituted pyrazole compoundsDYCKMAN ALARIC J·Filed 2010·Granted Mar 5, 2013·15 cites·14 claims
- 1785US7595317B2Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinasesBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Sep 29, 2009·7 cites·14 claims
- 1885US5710159AIntegrin receptor antagonistsDU PONT MERCK PHARMA·Filed 1996·Granted Jan 20, 1998·39 cites·21 claims
- 1984US5639759ACarbocyclic and heterocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agentsDU PONT MERCK PHARMA·Filed 1995·Granted Jun 17, 1997·46 cites·16 claims
- 2082US6596747B2Compounds derived from an amine nucleus and pharmaceutical compositions comprising sameBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Jul 22, 2003·20 cites·13 claims
- 2181US11440913B2Aminoimidazopyridazines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Sep 13, 2022·2 cites·14 claims
- 2281US9657009B2Heteroaryl substituted pyridyl compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted May 23, 2017·4 cites·11 claims
- 2381US7456194B2Imidazo-fused oxazolo [4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising sameBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Nov 25, 2008·5 cites·6 claims
- 2480US9546153B2Bicyclic heterocycle substituted pyridyl compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 17, 2017·5 cites·9 claims
- 2580US7737279B21,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising sameBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jun 15, 2010·4 cites·8 claims
- 2680US6919335B2Heterocycles that are inhibitors of IMPDH enzymeBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Jul 19, 2005·16 cites·22 claims
- 2779US7109224B2Acyl guanidine compounds and use thereofBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Sep 19, 2006·15 cites·16 claims
- 2879US2025074909A1Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 2978US9242975B2Heterocyclic-substituted pyridyl compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 26, 2016·4 cites·13 claims
- 3074US7557211B28H-imidazo[4,5-D]thiazolo[4,5-B]pyridine based tricyclic compounds and pharmaceutical compositions comprising sameBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jul 7, 2009·2 cites·6 claims
- 3172US5874441ACarbocyclic and hetertocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agentsDU PONT PHARM CO·Filed 1997·Granted Feb 23, 1999·23 cites·19 claims
- 3271US9242976B2Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 26, 2016·1 cites·7 claims
- 3370US8987268B2Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseasesWROBLESKI STEPHEN T·Filed 2012·Granted Mar 24, 2015·2 cites·14 claims
- 3468US10865191B2Heterocyclic compounds useful as modulators of TNF alphaBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Dec 15, 2020·1 cites·4 claims
- 3568US6110910ACarbocyclic heterocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agentsDU PONT PHARM CO·Filed 1998·Granted Aug 29, 2000·18 cites·16 claims
- 3667US12157733B2Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Dec 3, 2024·0 cites·6 claims
- 3767US7176214B2Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising sameBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Feb 13, 2007·3 cites·20 claims
- 3866US5932586AProstaglandin synthase inhibitorsDU PONT PHARM CO·Filed 1996·Granted Aug 3, 1999·21 cites·9 claims
- 3964US7329668B2Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising sameBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Feb 12, 2008·2 cites·17 claims
- 4060US7981881B2Fused heterocyclic compounds and use thereofBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jul 19, 2011·0 cites·9 claims
- 4159US5428040ACarbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agentsDU PONT MERCK PHARMA·Filed 1993·Granted Jun 27, 1995·10 cites·8 claims
- 4258US10544133B2Heteroaryl substituted pyridyl compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jan 28, 2020·0 cites·9 claims
- 4358US10227340B2Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Mar 12, 2019·0 cites·8 claims
- 4455US12275721B2Indazole carboxamides as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Apr 15, 2025·0 cites·12 claims
- 4554US10023562B2Heteroaryl substituted pyridyl compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jul 17, 2018·0 cites·11 claims
- 4654US2006217412A1Imidazo-fused oxazolo[4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising samePITTS WILLIAM J·Filed 2006·Application pending·0 cites
- 4753US7384937B2Fused heterocyclic compounds and use thereofBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jun 10, 2008·0 cites·12 claims
- 4851US12240840B2Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of IL-12, IL-23 and/or IFN-alphaBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Mar 4, 2025·0 cites·2 claims
- 4951US12084426B2Indazole carboxamides as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Sep 10, 2024·0 cites·13 claims
- 5050US2011230468A1Fused heterocyclic compounds and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2011·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when William J. Pitts files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →